Royal College of Surgeons in Ireland - Medical University of Bahrain
12
1
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.3%
1 terminated/withdrawn out of 12 trials
87.5%
+1.0% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Comparing the Olfactory Perception of a Fragrance-Loaded SpECs Over Time
Role: lead
Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers
Role: lead
Movement Behaviours Among Bahraini Diabetics
Role: lead
Hypoglycemia Biomarkers to Predict Timing of a Hypoglycemic Event
Role: lead
Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults
Role: lead
Date Fruit Effects in Type 2 Diabetes
Role: lead
Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19
Role: lead
Favipiravir vs Hydroxychloroquine vs Control in COVID -19
Role: lead
Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain
Role: lead
Convalescent Plasma Trial in COVID -19 Patients
Role: lead
Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19
Role: lead
Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
Role: collaborator
All 12 trials loaded